Legal & General Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.14M | Buy |
|
|||||
|
2025
Q2 | $7.15M | Buy |
|
|||||
|
2025
Q1 | $5.41M | Buy |
|
|||||
|
2024
Q4 | $2.44M | Buy |
|
|||||
|
2024
Q3 | $1.91M | Buy |
|
|||||
|
2024
Q2 | $1.98M | Buy |
|
|||||
|
2024
Q1 | $2.25M | Buy |
|
|||||
|
2023
Q4 | $3.63M | Buy |
|
|||||
|
2023
Q3 | $2.41M | Buy |
|
|||||
|
2023
Q2 | $2.75M | Sell |
|
|||||
|
2023
Q1 | $2.2M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Sell |
|
|||||
|
2022
Q3 | $1.83M | Sell |
|
|||||
|
2022
Q2 | $1.65M | Sell |
|
|||||
|
2022
Q1 | $2.9M | Buy |
|
|||||
|
2021
Q4 | $2.42M | Sell |
|
|||||
|
2021
Q3 | $1.78M | Buy |
|
|||||
|
2021
Q2 | $2.02M | Sell |
|
|||||
|
2021
Q1 | $3.41M | Sell |
|
|||||
|
2020
Q4 | $7.14M | Sell |
|
|||||
|
2020
Q3 | $6.05M | Sell |
|
|||||
|
2020
Q2 | $7.13M | Buy |
|
|||||
|
2020
Q1 | $3.3M | Buy |
|
|||||
|
2019
Q4 | $3.09M | Buy |
|
|||||
|
2019
Q3 | $2.16M | Buy |
|
|||||
|
2019
Q2 | $1.43M | Sell |
|
|||||
|
2019
Q1 | $1.46M | Buy |
|
|||||
|
2018
Q4 | $681K | Buy |
|
|||||
|
2018
Q3 | $712K | Hold |
|
|||||
|
2018
Q2 | $523K | Sell |
|
|||||
|
2018
Q1 | $1.09M | Sell |
|
|||||
|
2017
Q4 | $1.52M | Buy |
|
|||||
|
2017
Q3 | $1.49M | Buy |
|
|||||
|
2017
Q2 | $938K | Buy |
|
|||||
|
2017
Q1 | $1.13M | Buy |
|
|||||
|
2016
Q4 | $347K | Buy |
|
|||||
|
2016
Q3 | $343K | Buy |
|
|||||
|
2016
Q2 | $253K | Sell |
|
|||||
|
2016
Q1 | $536K | Buy |
|
|||||
|
2015
Q4 | $581K | Buy |
|
|||||
|
2015
Q3 | $503K | Buy |
|
|||||
|
2015
Q2 | $585K | Sell |
|
|||||
|
2015
Q1 | $505K | Buy |
|
|||||
|
2014
Q4 | $396K | Sell |
|
|||||
|
2014
Q3 | $318K | Buy |
|